Reuters logo
BRIEF-Flex Pharma initiates CMT phase 2 trial with FLX-787 in US
October 16, 2017 / 12:41 PM / a month ago

BRIEF-Flex Pharma initiates CMT phase 2 trial with FLX-787 in US

Oct 16 (Reuters) - Flex Pharma Inc

* Flex Pharma initiates CMT phase 2 trial with FLX-787 in US

* Flex Pharma Inc - ‍ALS phase 2 trial currently underway​

* Flex Pharma Inc - ‍expects to report topline results from this study in middle of 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below